STOCK TITAN

[Form 4] Gyrodyne, LLC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

On 08/04/2025, 10% owner Towerview LLC filed a Form 4 reporting the sale of 1,216 Gyrodyne (GYRO) common shares at $12.10 each. Post-transaction, the reporting person still owns 340,080 shares directly. The disposition equals roughly 0.4% of Towerview’s prior position, signalling only a modest trim rather than a material change in ownership. No derivative securities were listed in Table II and no other transactions were disclosed.

Il 08/04/2025, Towerview LLC, proprietario del 10%, ha presentato un Modulo 4 segnalando la vendita di 1.216 azioni ordinarie Gyrodyne (GYRO) a 12,10 $ ciascuna. Dopo la transazione, la persona che ha effettuato la segnalazione possiede ancora direttamente 340.080 azioni. La cessione corrisponde a circa lo 0,4% della posizione precedente di Towerview, indicando una riduzione modesta piuttosto che un cambiamento rilevante nella proprietà. Non sono stati elencati titoli derivati nella Tabella II e non sono state divulgate altre transazioni.

El 08/04/2025, Towerview LLC, propietario del 10%, presentó un Formulario 4 reportando la venta de 1.216 acciones comunes de Gyrodyne (GYRO) a 12,10 $ cada una. Tras la transacción, la persona informante aún posee directamente 340.080 acciones. La disposición equivale aproximadamente al 0,4% de la posición previa de Towerview, señalando solo una reducción modesta en lugar de un cambio significativo en la propiedad. No se listaron valores derivados en la Tabla II ni se divulgaron otras transacciones.

2025년 4월 8일, 10% 소유주인 Towerview LLC가 Form 4를 제출하여 Gyrodyne(GYRO) 보통주 1,216주를 주당 12.10달러에 매도했다고 보고했습니다. 거래 후 보고자는 여전히 직접 340,080주를 보유하고 있습니다. 처분된 주식은 Towerview의 이전 보유량의 약 0.4%에 해당하며, 이는 소유권의 중대한 변화보다는 단순한 소폭 조정임을 나타냅니다. 표 II에는 파생 증권이 기재되지 않았으며, 다른 거래도 공개되지 않았습니다.

Le 08/04/2025, Towerview LLC, propriétaire de 10 %, a déposé un formulaire 4 signalant la vente de 1 216 actions ordinaires Gyrodyne (GYRO) à 12,10 $ chacune. Après la transaction, la personne déclarant détient encore 340 080 actions directement. La cession représente environ 0,4 % de la position précédente de Towerview, indiquant une réduction modeste plutôt qu’un changement significatif de propriété. Aucun titre dérivé n’a été listé dans le tableau II et aucune autre transaction n’a été divulguée.

Am 08.04.2025 meldete Towerview LLC, ein 10%-Eigentümer, mittels Formular 4 den Verkauf von 1.216 Gyrodyne (GYRO) Stammaktien zu je 12,10 $. Nach der Transaktion besitzt die meldende Person weiterhin 340.080 Aktien direkt. Die Veräußerung entspricht etwa 0,4 % der vorherigen Position von Towerview und signalisiert lediglich eine moderate Reduzierung, nicht jedoch eine wesentliche Änderung der Eigentumsverhältnisse. In Tabelle II wurden keine Derivate aufgeführt und es wurden keine weiteren Transaktionen offengelegt.

Positive
  • None.
Negative
  • 10% owner sold 1,216 shares; insider selling can be interpreted as a mildly negative signal, though the amount is immaterial relative to holdings.

Insights

Minor 1,216-share sale by 10% owner; ownership remains large at 340k shares, therefore limited signal value for investors.

Gyrodyne’s Form 4 shows Towerview LLC—classified as a 10 % owner—sold 1,216 common shares on 08/04/2025 at $12.10. After the sale, Towerview still directly holds 340,080 shares. The divestiture represents about 0.4% of its stake, suggesting no significant shift in strategic intent or insider sentiment. No derivative positions or additional insider trades were reported, and the filing does not reference a Rule 10b5-1 plan. Given the small size relative to total ownership and lack of accompanying corporate events, the market impact appears neutral.

Il 08/04/2025, Towerview LLC, proprietario del 10%, ha presentato un Modulo 4 segnalando la vendita di 1.216 azioni ordinarie Gyrodyne (GYRO) a 12,10 $ ciascuna. Dopo la transazione, la persona che ha effettuato la segnalazione possiede ancora direttamente 340.080 azioni. La cessione corrisponde a circa lo 0,4% della posizione precedente di Towerview, indicando una riduzione modesta piuttosto che un cambiamento rilevante nella proprietà. Non sono stati elencati titoli derivati nella Tabella II e non sono state divulgate altre transazioni.

El 08/04/2025, Towerview LLC, propietario del 10%, presentó un Formulario 4 reportando la venta de 1.216 acciones comunes de Gyrodyne (GYRO) a 12,10 $ cada una. Tras la transacción, la persona informante aún posee directamente 340.080 acciones. La disposición equivale aproximadamente al 0,4% de la posición previa de Towerview, señalando solo una reducción modesta en lugar de un cambio significativo en la propiedad. No se listaron valores derivados en la Tabla II ni se divulgaron otras transacciones.

2025년 4월 8일, 10% 소유주인 Towerview LLC가 Form 4를 제출하여 Gyrodyne(GYRO) 보통주 1,216주를 주당 12.10달러에 매도했다고 보고했습니다. 거래 후 보고자는 여전히 직접 340,080주를 보유하고 있습니다. 처분된 주식은 Towerview의 이전 보유량의 약 0.4%에 해당하며, 이는 소유권의 중대한 변화보다는 단순한 소폭 조정임을 나타냅니다. 표 II에는 파생 증권이 기재되지 않았으며, 다른 거래도 공개되지 않았습니다.

Le 08/04/2025, Towerview LLC, propriétaire de 10 %, a déposé un formulaire 4 signalant la vente de 1 216 actions ordinaires Gyrodyne (GYRO) à 12,10 $ chacune. Après la transaction, la personne déclarant détient encore 340 080 actions directement. La cession représente environ 0,4 % de la position précédente de Towerview, indiquant une réduction modeste plutôt qu’un changement significatif de propriété. Aucun titre dérivé n’a été listé dans le tableau II et aucune autre transaction n’a été divulguée.

Am 08.04.2025 meldete Towerview LLC, ein 10%-Eigentümer, mittels Formular 4 den Verkauf von 1.216 Gyrodyne (GYRO) Stammaktien zu je 12,10 $. Nach der Transaktion besitzt die meldende Person weiterhin 340.080 Aktien direkt. Die Veräußerung entspricht etwa 0,4 % der vorherigen Position von Towerview und signalisiert lediglich eine moderate Reduzierung, nicht jedoch eine wesentliche Änderung der Eigentumsverhältnisse. In Tabelle II wurden keine Derivate aufgeführt und es wurden keine weiteren Transaktionen offengelegt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
TOWERVIEW LLC

(Last) (First) (Middle)
499 PARK AVENUE

(Street)
NEW YORK NY 10022

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Gyrodyne, LLC [ GYRO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/04/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 08/04/2025 S 1,216 D $12.1 340,080 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Daniel R. Tisch 08/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Gyrodyne (GYRO) shares did Towerview LLC sell?

Towerview LLC sold 1,216 common shares on 08/04/2025.

At what price were the shares sold?

The shares were sold at $12.10 per share.

How many GYRO shares does Towerview LLC own after the sale?

Towerview LLC now directly owns 340,080 shares.

What proportion of Towerview’s stake was sold?

The sale represents roughly 0.4 % of its prior holding.

Were any derivative securities involved in the transaction?

No; Table II shows no derivative trades.

Does the Form 4 indicate use of a Rule 10b5-1 trading plan?

The filing does not indicate that the sale was executed under a Rule 10b5-1 plan.
Gyrodyne Llc

NASDAQ:GYRO

GYRO Rankings

GYRO Latest News

GYRO Latest SEC Filings

GYRO Stock Data

22.08M
1.50M
31.95%
36.97%
0.03%
Real Estate Services
Operators of Nonresidential Buildings
Link
United States
ST. JAMES